Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127809751 | 12780975 | 1 | I | 201604 | 20160916 | 20160926 | 20160926 | EXP | FR-INDIVIOR LIMITED-INDV-095046-2016 | INDIVIOR | 36.75 | YR | M | Y | 0.00000 | 20160926 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127809751 | 12780975 | 1 | PS | SUBUTEX | BUPRENORPHINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 3 MG, DAILY | U | U | UNKNOWN | 20732 | 3 | MG | SUBLINGUAL TABLET | ||||
| 127809751 | 12780975 | 2 | SS | ALCOHOL. | ALCOHOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 127809751 | 12780975 | 3 | SS | TRAMADOL. | TRAMADOL | 1 | Unknown | (100MG) ADMINISTERED 7 TABLETS | U | 0 | |||||||||
| 127809751 | 12780975 | 4 | C | DEPAKOTE | DIVALPROEX SODIUM | 1 | Unknown | (500MG) 2 DOSAGE FORM IN THE MORNING AND THE EVENING | 0 | ||||||||||
| 127809751 | 12780975 | 5 | C | SERESTA | OXAZEPAM | 1 | Unknown | (50 MG) AT 1 DOSAGE FORM IN THE MORNING AT NOON AND IN THE EVENING | 0 | ||||||||||
| 127809751 | 12780975 | 6 | C | TERCIAN /00759301/ | CYAMEMAZINE | 1 | Unknown | (100 MG) A HALF DOSAGE FORM THREE TIME PER DAY | 0 | ||||||||||
| 127809751 | 12780975 | 7 | C | HALDOL DECANOATE | HALOPERIDOL DECANOATE | 1 | Intramuscular | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127809751 | 12780975 | 1 | Product used for unknown indication |
| 127809751 | 12780975 | 2 | Product used for unknown indication |
| 127809751 | 12780975 | 3 | Product used for unknown indication |
| 127809751 | 12780975 | 4 | Product used for unknown indication |
| 127809751 | 12780975 | 5 | Product used for unknown indication |
| 127809751 | 12780975 | 6 | Product used for unknown indication |
| 127809751 | 12780975 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127809751 | 12780975 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127809751 | 12780975 | Intentional product use issue | |
| 127809751 | 12780975 | Sepsis | |
| 127809751 | 12780975 | Subcutaneous abscess |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |